Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PT Multi Indocitra Tbk's Marketable Securities for the quarter that ended in Jun. 2026 was Rp1,200 Mil.
PT Multi Indocitra Tbk's annual Marketable Securities
declined
from Dec. 2023 (Rp1,488 Mil) to Dec. 2024 (Rp1,248 Mil) but then
increased
from Dec. 2024 (Rp1,248 Mil) to Dec. 2025 (Rp1,464 Mil).
PT Multi Indocitra Tbk (ISX:MICE) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
PT Multi Indocitra Tbk Marketable Securities Related Terms
PT Multi Indocitra Tbk Marketable Securities Historical Data
* Premium members only.
The historical data trend for PT Multi Indocitra Tbk's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Multi Indocitra Tbk Marketable Securities Chart
What does a Marketable Securities of Rp1,200 Mil mean?
PT Multi Indocitra Tbk (ISX:MICE) has a Marketable Securities of Rp1,200 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Multi Indocitra Tbk and its competitors.
Is PT Multi Indocitra Tbk's Marketable Securities too high?
PT Multi Indocitra Tbk's current Marketable Securities is Rp1,200 Mil. Overall, PT Multi Indocitra Tbk has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Multi Indocitra Tbk's Marketable Securities compare to PG and CL?
PT Multi Indocitra Tbk's Marketable Securities of Rp1,200 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Consumer Packaged Goods company?
A good Marketable Securities depends on the Consumer Packaged Goods industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Multi Indocitra Tbk and its competitors. PT Multi Indocitra Tbk's current Marketable Securities is Rp1,200 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Indocitra Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Multi Indocitra Tbk (ISX:MICE) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp594.96, compared to a current price of Rp520.00 — trading 12.6% below its estimated fair value. The current Marketable Securities is Rp1,200 Mil. PT Multi Indocitra Tbk's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PT Multi Indocitra Tbk (ISX:MICE), the current Marketable Securities is Rp1,200 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Multi Indocitra Tbk (ISX:MICE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Multi Indocitra Tbk stock appears to be undervalued.
The current stock price of Rp520.00 is trading 12.6% below its estimated GF Value™ of Rp594.96.
GuruFocus considers PT Multi Indocitra Tbk to be Modestly Undervalued.
Key valuation signals for ISX:MICE:
Marketable Securities: Rp1,200 Mil
GF Value™: Rp594.96 vs. price of Rp520.00 (12.6% below fair value)
No single metric tells the full story. See the ISX:MICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Multi Indocitra Tbk is mainly engaged in general trading of commercial baby's products and health care and cosmetics products. The Company produces and distributes consumer goods of baby and health care products and cosmetics. The company's Business segments are Trading, Services, and Industry. The company generates majority of revenue from Trading segment. The company's brands are Pigeon Baby, Pigeon Teens, Kaila, Kaila Beaute, Feira White, Mattel Indonesia, Youvit, HORI, HOYA, Lansinoh, Amara, Poipoi, Granova, Bumil.
86GF Score
Get the complete analysis for ISX:MICE
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MICE has been successfully added to your 
